SOLNA, STOCKHOLM REGION, SWEDEN – August 26, 2025 – Barnik Invest, a leading
360 solution investment partner for Life Science companies, today announced its
participation in the Advanced Therapies Europe 2025 conference. The exclusive event,
taking place from September 2-4 in Barcelona, will bring together 500 of the most
influential minds in cell and gene therapy, including therapeutic developers, pharma
leaders, CDMOs, and investors.
The conference is designed to accelerate innovation, investment, and
commercialization across the advanced therapies landscape. Barnik Invest will be
actively involved in high-impact networking and strategic discussions, seeking new
investment opportunities and partnerships.
The event is known for its curated content, including plenary sessions and workshops,
as well as exclusive experiences like the Investor Summit, which is tailored for
meaningful discussion and strategic alignment. Barnik Invest looks forward to
engaging in these focused conversations to find the next wave of therapeutic
innovation.
Barnik Invest will be represented at the event by CEO Hamid Bakhshi and COO Sara
Nikman, and invites interested parties to reach out via the partnering platform to
schedule meetings and explore potential collaboration opportunities.
For more information, please contact;
Hamid Bakhshi, CEO
Telephone: +46738531165
E-mail: info@barnikinvest.com
About Barnik Invest Group
Barnik Invest Group is a leading 360 solution partner for Life Science companies in the
Nordics. The company provides a comprehensive suite of services to support its portfolio
companies, including capital, clinical development, expertise, and commercialization.
Through its fully owned subsidiaries, Medicorent and StartUpPharma, Barnik Invest offers
CRO services, outsourcing, recruitment, distribution, product development, and
commercialization solutions. Barnik’s mission is to nurture promising life science
companies from early clinical development to commercialization, enabling them to achieve
positive cash flows or successful exits, and ultimately enhancing patient well-being and
improving human health worldwide. For more information, visit www.barnikinvest.com.
